ETFIQData as of Nov 19, 2026. · etfiq.com/funds/fmed

FMED Fact Sheet: Fidelity Disruptive Medicine ETF

Share
$32.74
close, Nov 20, 2026

Over the year to Nov 19, 2026, FMED returned +19.6% in total and charged 0.50% a year.

1-year total return
+20.2%
to Nov 20, 2026
Expense ratio
0.50%
a year
Net assets
$53m
on Oct 31, 2026
Net flow, 12 months to Aug 31, 2026
−$14.6m
monthly N-PORT basis to Aug 31, 2026

Growth of $10,000, 1 year

FMED $11,957 +19.6% · Total return, distributions reinvested, Nov 19, 2025 to Nov 19, 2026.

Returns

WindowTotal return
1 month+2.3%
3 months+0.6%
Year to date+21.0%
1 year+20.2%
3 years+53.8%

Total return, distributions reinvested, each window to Nov 20, 2026.

Ten largest positions

HoldingWeight
10X GENOMICS INC5.19%
THERMO FISHER SCIENTIFIC INC3.83%
DANAHER CORP3.73%
NATERA INC3.30%
ARGENX SE3.20%
LIFESTANCE HEALTH GROUP INC3.00%
REVOLUTION MEDICINES INC2.87%
ILLUMINA INC2.82%
MODERNA INC2.72%
HEARTFLOW INC2.59%

FMED top ten by weight, 33.2% of the fund, of its 72 equity positions, from the holdings filed for Aug 31, 2026.

Facts

Holds 72 stocks in broad innovation and megatrends, 22% of its weight in S&P 500 companies · First traded Jun 12, 2023 · Benchmark Its own holdings, as of Aug 31, 2026; its prospectus names no index it tracks

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, FMED Fact Sheet: Fidelity Disruptive Medicine ETF. Data as of Nov 19, 2026. https://etfiq.com/funds/fmed/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/fmed.